<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03862196</url>
  </required_header>
  <id_info>
    <org_study_id>NGOViaLibre</org_study_id>
    <nct_id>NCT03862196</nct_id>
  </id_info>
  <brief_title>Efficacy of SMS to Improve Early Retention in HIV Care for PLWH in Lima</brief_title>
  <official_title>Efficacy of an Intervention With Text Messaging to Improve Early Retention in HIV Care for People With HIV Who Receive Treatment at VIA LIBRE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NGO Via Libre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NGO Via Libre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled study that will evaluate the effect of a text message-based strategy to
      improve retention in HIV care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized controlled pilot study with a parallel 2-arm design. It will evaluate
      the effect of a text message-based strategy to improve retention in HIV care at the study
      clinic, compared to the standard of care. Trained counselors will deliver the text messages.
      After a block randomization, the trained counselor (a nurse) will send the first welcoming
      message to participants in the intervention arm. The nurse will send 2 tailored text messages
      per week. In addition 2 to 4 days before an appointment, the nurse will send a message
      reminder. In addition, the nurse will have bilateral communication with participants using
      text messages according to their needs. The participants of the intervention arm will
      interact with the nurse during 3 months with a semi-structured strategy, that is, with
      template text messages (predesigned) and open messages (for which the nurse will be trained).
      Three and six months after started the intervention the variables of interest will be
      assessed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 21, 2018</start_date>
  <completion_date type="Anticipated">August 7, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 11, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled pilot study with a parallel 2-arm design.The intervention arm will receive 2 tailored text messages weekly from a trained counselor during 3 months. The control arm will receive the standard of care, which consists of pre and post counseling after the HIV diagnosis and referral to a health facility to start antiretroviral treatment.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Care Provider)</masking>
    <masking_description>After consenting, participants will be randomly assigned to the intervention or control with a 1:1 ratio and random block sizes of 2 and 4 using computer generated random numbers. Block sizes will not be disclosed. Allocations will be sealed in individual, sequentially numbered opaque envelopes. The RECRUITER, who will be masked to the group assignment, will give instructions to all participants on how they should interact if they start receiving SMS. After completing the baseline survey, one of the principal investigators will assign the participant to a group by opening the corresponding envelope. The PI will report to one of trained providers in charge of delivering the intervention (different from recruiters) when a new participant of the intervention arm is enrolled. Because of the nature of the participation, providers and participants will not be masked to group assignment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Retention in timely monitoring of viral load (VL)</measure>
    <time_frame>6 months</time_frame>
    <description>Rate of participants with a second lab result of VL available 6 months after initiation of ART, verified using lab records</description>
  </primary_outcome>
  <other_outcome>
    <measure>Retention in HIV care</measure>
    <time_frame>3 months</time_frame>
    <description>Rate of participants who attended the 2nd and 3rd appointments for HIV care at the study clinic, verified using medical records</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive 2 tailored text messages weekly from a trained counselor during 3 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will receive standard of care: pre and post counseling after being diagnosed with HIV</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tailored text messages to improve retention in HIV care</intervention_name>
    <description>Trained counselors will deliver the text messages. After a block randomization, the trained counselor (a nurse) will send the first welcoming message to participants in the intervention arm. The nurse will send 2 tailored text messages per week. In addition 2 to 4 days before an appointment, the nurse will send a message reminder. In addition, the nurse will have bilateral communication with participants using text messages according to their needs. The participants of the intervention arm will interact with the nurse during 3 months with a semi-structured strategy, that is, with template text messages (predesigned) and open messages (for which the nurse will be trained). Three and six months after started the intervention the variables of interest will be assessed.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male 18 years old or older.

          -  Linked to HIV care at the study clinic.

          -  Have a cell phone.

          -  Diagnosed at the study clinic of referred from other center to start ART.

          -  Give consent to participate.

        Exclusion Criteria:

          -  Enrolled in other HIV study using text messages.

          -  Have started ART.

          -  Enrolled in a clinical trial.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Robinson Cabello, MD</last_name>
    <phone>512039900</phone>
    <phone_ext>110</phone_ext>
    <email>rcabello@vialibre.org.pe</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luis Menacho, MD, MPH</last_name>
    <phone>51991671979</phone>
    <email>luchomenacho@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Via Libre</name>
      <address>
        <city>Lima</city>
        <zip>Lima1</zip>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robinson Cabello, MD</last_name>
      <phone>012039900</phone>
      <email>rcabello@vialibre.org.pe</email>
    </contact>
    <contact_backup>
      <last_name>Maria Romero, BSN</last_name>
      <phone>012039900</phone>
      <email>mromero.vialibre@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Peru</country>
  </location_countries>
  <reference>
    <citation>Menacho L, Garcia PJ, Blas MM, Díaz G, Zunt JR. What Men Who Have Sex With Men in Peru Want in Internet-Based Sexual Health Information. J Homosex. 2018;65(7):934-946. doi: 10.1080/00918369.2017.1364939. Epub 2017 Sep 22.</citation>
    <PMID>28820663</PMID>
  </reference>
  <reference>
    <citation>AIDS by the numbers. UNAIDS, 2016. Retrieved from: http://www.unaids.org/sites/default/files/media_asset/AIDS-by-the-numbers2016_en.pdf</citation>
  </reference>
  <reference>
    <citation>UNAIDS country Peru report, 2016. Retrieved from: http://www.unaids.org/en/regionscountries/countries/peru</citation>
  </reference>
  <reference>
    <citation>Chow JY, Konda KA, Borquez A, Caballero P, Silva-Santisteban A, Klausner JD, Cáceres CF. Peru's HIV care continuum among men who have sex with men and transgender women: opportunities to optimize treatment and prevention. Int J STD AIDS. 2016 Oct;27(12):1039-1048. Epub 2016 Apr 20. Review.</citation>
    <PMID>27099168</PMID>
  </reference>
  <reference>
    <citation>Wolff MJ, Cortes CP, Mejìa FA, Padgett D, Belaunzarán-Zamudio P, Grinsztejn B, Giganti MJ, McGowan CC, Rebeiro PF; Caribbean, Central and South America network for HIV epidemiology (CCASAnet). Evaluating the care cascade after antiretroviral therapy initiation in Latin America. Int J STD AIDS. 2018 Jan;29(1):4-12. doi: 10.1177/0956462417714094. Epub 2017 Jun 15.</citation>
    <PMID>28618980</PMID>
  </reference>
  <reference>
    <citation>Prevention gap report. UNAIDS, 2016. Retrieved from: http://www.unaids.org/sites/default/files/media_asset/2016-prevention-gapreport_en.pdf</citation>
  </reference>
  <reference>
    <citation>Consolidated guidelines on the use of antiretroviral drugs for treating and preventing hiv infection recommendations for a public health approach, second edition 2016. World Health Organisation.</citation>
  </reference>
  <reference>
    <citation>Muessig KE, LeGrand S, Horvath KJ, Bauermeister JA, Hightow-Weidman LB. Recent mobile health interventions to support medication adherence among HIV-positive MSM. Curr Opin HIV AIDS. 2017 Sep;12(5):432-441. doi: 10.1097/COH.0000000000000401. Review.</citation>
    <PMID>28639990</PMID>
  </reference>
  <reference>
    <citation>Rana AI, van den Berg JJ, Lamy E, Beckwith CG. Using a Mobile Health Intervention to Support HIV Treatment Adherence and Retention Among Patients at Risk for Disengaging with Care. AIDS Patient Care STDS. 2016 Apr;30(4):178-84. doi: 10.1089/apc.2016.0025.</citation>
    <PMID>27028183</PMID>
  </reference>
  <reference>
    <citation>Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, Jack W, Habyarimana J, Sadatsafavi M, Najafzadeh M, Marra CA, Estambale B, Ngugi E, Ball TB, Thabane L, Gelmon LJ, Kimani J, Ackers M, Plummer FA. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010 Nov 27;376(9755):1838-45. doi: 10.1016/S0140-6736(10)61997-6. Epub 2010 Nov 9.</citation>
    <PMID>21071074</PMID>
  </reference>
  <reference>
    <citation>Bayona E, Menacho L, Segura ER, Mburu G, Roman F, Tristan C, Bromley E, Cabello R. The Experiences of Newly Diagnosed Men Who Have Sex with Men Entering the HIV Care Cascade in Lima, Peru, 2015-2016: A Qualitative Analysis of Counselor-Participant Text Message Exchanges. Cyberpsychol Behav Soc Netw. 2017 Jun;20(6):389-396. doi: 10.1089/cyber.2016.0435.</citation>
    <PMID>28622034</PMID>
  </reference>
  <reference>
    <citation>Yu Y, Luo D, Chen X, Huang Z, Wang M, Xiao S. Medication adherence to antiretroviral therapy among newly treated people living with HIV. BMC Public Health. 2018 Jul 4;18(1):825. doi: 10.1186/s12889-018-5731-z.</citation>
    <PMID>29973167</PMID>
  </reference>
  <reference>
    <citation>Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002 Apr 15;34(8):1115-21. Epub 2002 Mar 11.</citation>
    <PMID>11915001</PMID>
  </reference>
  <reference>
    <citation>Menacho LA, Blas MM, Alva IE, Roberto Orellana E. Short Text Messages to Motivate HIV Testing Among Men Who have Sex with Men: A Qualitative Study in Lima, Peru. Open AIDS J. 2013 Apr 5;7:1-6. doi: 10.2174/1874613601307010001. Print 2013.</citation>
    <PMID>23802032</PMID>
  </reference>
  <reference>
    <citation>Young SD, Cumberland WG, Nianogo R, Menacho LA, Galea JT, Coates T. The HOPE social media intervention for global HIV prevention in Peru: a cluster randomised controlled trial. Lancet HIV. 2015 Jan;2(1):e27-32.</citation>
    <PMID>26236767</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>November 28, 2018</study_first_submitted>
  <study_first_submitted_qc>March 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2019</study_first_posted>
  <last_update_submitted>March 1, 2019</last_update_submitted>
  <last_update_submitted_qc>March 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>NGO Via Libre</investigator_affiliation>
    <investigator_full_name>ROBINSON CABELLO</investigator_full_name>
    <investigator_title>Executive Director</investigator_title>
  </responsible_party>
  <keyword>prevention</keyword>
  <keyword>retention</keyword>
  <keyword>mHealth</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 7, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/96/NCT03862196/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

